173 related articles for article (PubMed ID: 25053391)
1. Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice.
Hassan MH; El-Beshbishy HA; Aly H; Attia SM; Bahashwan SA; Ghobara MM
Cancer Chemother Pharmacol; 2014 Sep; 74(3):559-69. PubMed ID: 25053391
[TBL] [Abstract][Full Text] [Related]
2. Modulator effects of meloxicam against doxorubicin-induced nephrotoxicity in mice.
Hassan MH; Ghobara M; Abd-Allah GM
J Biochem Mol Toxicol; 2014 Aug; 28(8):337-46. PubMed ID: 24799355
[TBL] [Abstract][Full Text] [Related]
3. Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma.
Ali SA; Zaitone SA; Moustafa YM
Can J Physiol Pharmacol; 2015 Aug; 93(8):695-708. PubMed ID: 26230640
[TBL] [Abstract][Full Text] [Related]
4. Meloxicam modulates oxidative stress status, inhibits prostaglandin E2, and abrogates apoptosis in carbon tetrachloride-induced rat hepatic injury.
Edfawy M; Hassan MH; Mansour A; Hamed AA; Amin HA
Int J Toxicol; 2012 Jun; 31(3):276-86. PubMed ID: 22556387
[TBL] [Abstract][Full Text] [Related]
5. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study.
Villegas I; Martín MJ; La Casa C; Motilva V; De La Lastra CA
Free Radic Res; 2002 Jul; 36(7):769-77. PubMed ID: 12180128
[TBL] [Abstract][Full Text] [Related]
6. Abatement by naringenin of doxorubicin-induced cardiac toxicity in rats.
Arafa HM; Abd-Ellah MF; Hafez HF
J Egypt Natl Canc Inst; 2005 Dec; 17(4):291-300. PubMed ID: 17102822
[TBL] [Abstract][Full Text] [Related]
7. Anti-fibrotic effect of meloxicam in a murine lung fibrosis model.
Arafa HM; Abdel-Wahab MH; El-Shafeey MF; Badary OA; Hamada FM
Eur J Pharmacol; 2007 Jun; 564(1-3):181-9. PubMed ID: 17462625
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR
Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331
[TBL] [Abstract][Full Text] [Related]
9. 6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation.
El-Bakly WM; Louka ML; El-Halawany AM; Schaalan MF
Cancer Chemother Pharmacol; 2012 Dec; 70(6):833-41. PubMed ID: 23014738
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice.
Lin MC; Yin MC
Cardiovasc Toxicol; 2013 Sep; 13(3):185-93. PubMed ID: 23322372
[TBL] [Abstract][Full Text] [Related]
11. Effects of meloxicam on oxygen radical generation in rat gastric mucosa.
Villegas I; Martín MJ; La Casa C; Motilva V; Alarcón de la Lastra C
Inflamm Res; 2000 Jul; 49(7):361-6. PubMed ID: 10959558
[TBL] [Abstract][Full Text] [Related]
12. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.
Villegas I; Alarcón de la Lastra C; La Casa C; Motilva V; Martín MJ
Eur J Pharmacol; 2001 Feb; 414(1):79-86. PubMed ID: 11230998
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity.
Kang YJ; Chen Y; Yu A; Voss-McCowan M; Epstein PN
J Clin Invest; 1997 Sep; 100(6):1501-6. PubMed ID: 9294117
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.
Ammar el-SM; Said SA; Suddek GM; El-Damarawy SL
Can J Physiol Pharmacol; 2011 Apr; 89(4):269-76. PubMed ID: 21526973
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression.
Khafaga AF; El-Sayed YS
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):59-70. PubMed ID: 29085977
[TBL] [Abstract][Full Text] [Related]
16. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
Yu X; Cui L; Zhang Z; Zhao Q; Li S
Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
[TBL] [Abstract][Full Text] [Related]
17. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats.
Elberry AA; Abdel-Naim AB; Abdel-Sattar EA; Nagy AA; Mosli HA; Mohamadin AM; Ashour OM
Food Chem Toxicol; 2010 May; 48(5):1178-84. PubMed ID: 20146931
[TBL] [Abstract][Full Text] [Related]
18. Modulation of glutathione and glutathione dependent antioxidant enzymes in mouse heart following doxorubicin therapy.
Gustafson DL; Swanson JD; Pritsos CA
Free Radic Res Commun; 1993; 19(2):111-20. PubMed ID: 8225037
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of ivabradine on hemodynamic parameters and cardiotoxicity induced by doxorubicin treatment in rat.
Colak MC; Parlakpinar H; Tasdemir S; Samdanci E; Kose E; Polat A; Sarihan E; Acet A
Hum Exp Toxicol; 2012 Sep; 31(9):945-54. PubMed ID: 22354086
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of 'Khamira Abresham Hakim Arshad Wala', a unani formulation against doxorubicin-induced cardiotoxicity and nephrotoxicity.
Nazmi AS; Ahmad SJ; Rashikh A; Akhtar M; Pillai KK; Najmi AK
Toxicol Mech Methods; 2011 Jan; 21(1):41-7. PubMed ID: 21067281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
